Friday, August 28, 2020 12:02:42 PM
Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Announcement - Center for Biologics Evaluation and Research
https://www.fda.gov/advisory-committees/advisory-committee-calendar
FDA Advisory Committee Calendar
U.S. Food and Drug Administration
Search FDA
Home Advisory Committees Advisory Committee Calendar
Advisory Committee Calendar
Share
Tweet
This page contains notices of advisory committee meetings. For previous years' advisory committee calendars, see the FDA ArchiveExternal Link Disclaimer.
Search
Showing 1 to 10 of 269 entries
Show
10
entries
Start Date End Date Meeting Center
10/22/2020 10:00 AM EDT 10/22/2020 05:00 PM EDT October 22, 2020: Patient Engagement Advisory Committee Meeting Announcement - 10/22/2020 - 10/22/2020 Center for Devices and Radiological Health
10/22/2020 10:00 AM EDT 10/22/2020 05:00 PM EDT Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Announcement - 10/22/2020 - 10/22/2020 Center for Biologics Evaluation and Research
10/07/2020 09:00 AM EDT 10/07/2020 06:00 PM EDT October 7, 2020: Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting Announcement - 10/07/2020 - 10/07/2020 Center for Devices and Radiological Health
10/02/2020 11:00 AM EDT 10/02/2020 03:30 PM EDT Vaccines and Related Biological Products Advisory Committee October 2, 2020 Meeting Announcement - 10/02/2020 - 10/02/2020 Center for Biologics Evaluation and Research
09/15/2020 10:00 AM EDT 09/15/2020 04:30 PM EDT Pediatric Advisory Committee Meeting Announcement - 09/15/2020 - 09/15/2020 Office of the Commissioner, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health
09/10/2020 09:00 AM EDT 09/11/2020 05:00 PM EDT September 10-11, 2020 Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee Meeting Announcement - 09/10/2020 - 09/11/2020 Center for Drug Evaluation and Research
09/08/2020 08:00 AM EDT 09/09/2020 01:00 PM EDT September 8-9, 2020: Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee Meeting Announcement - 09/08/2020 - 09/09/2020 Center for Devices and Radiological Health
08/31/2020 10:00 AM EDT 08/31/2020 04:00 PM EDT UPDATED PUBLIC PARTICIPATION INFORMATION: August 31, 2020: Meeting of the Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement - 08/31/2020 - 08/31/2020 Center for Drug Evaluation and Research
08/18/2020 09:00 AM EDT 08/19/2020 12:30 PM EDT August 18-19, 2020: Science Advisory Board to the National Center for Toxicological Research 2020 Meeting Announcement - 08/18/2020 - 08/19/2020 National Center for Toxicological Research
08/13/2020 08:00 AM EDT 08/13/2020 05:00 PM EDT August 13, 2020: Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement - 08/13/2020 - 08/13/2020 Center for Drug Evaluation and Research
Showing 1 to 10 of 269 entries
Previous12345…27Next
Content current as of:
08/28/2020
Topic(s)
Research
Public Awareness
Training & Education
Advisory Committee Calendar
Footer Links
FDA Archive
About FDA
Accessibility
Visitor Information
Website Policies / Privacy
No FEAR Act
FOIA
HHS.gov
USA.gov
https://www.fda.gov/advisory-committees/advisory-committee-calendar
Recent PFE News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2025 06:27:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2025 06:25:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2025 06:24:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2025 04:50:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2025 04:47:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2025 04:47:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2025 02:49:42 PM
- U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer • Business Wire • 12/20/2024 07:03:00 PM
- Pfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with Analysts • Business Wire • 12/19/2024 03:00:00 PM
- Dow May Regain Ground After Longest Losing Streak Since 1978 • IH Market News • 12/18/2024 02:03:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/17/2024 10:20:01 PM
- Dow Extends Losing Streak To Nine Days, Nasdaq Pulls Back Off Record High • IH Market News • 12/17/2024 09:38:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/17/2024 01:05:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2024 12:47:10 PM
- Pfizer Provides Full-Year 2025 Guidance and Reaffirms Full-Year 2024 Guidance • Business Wire • 12/17/2024 11:45:00 AM
- Pfizer Declares First-Quarter 2025 Dividend • Business Wire • 12/12/2024 10:25:00 PM
- Pfizer’s IBRANCE® in Combination with Standard-of-Care Therapies Extends Median Progression-Free Survival by Over 15 Months in Phase 3 PATINA Study in Patients with HR+, HER2+ Metastatic Breast Cancer • Business Wire • 12/12/2024 01:15:00 PM
- Pfizer Invites Public to View and Listen to Webcast of December 17 Conference Call with Analysts to Provide Full-Year 2025 Financial Guidance • Business Wire • 12/10/2024 03:00:00 PM
- Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub-Study of Vepdegestrant in Combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium • GlobeNewswire Inc. • 12/10/2024 02:05:00 PM
- Pfizer Showcases Scientific Leadership in Breast Cancer and Blood Disorders Across More than 100 Presentations at ASH and SABCS • Business Wire • 12/05/2024 10:06:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2024 09:18:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2024 09:18:17 PM
- Pfizer Announces New Chief Scientific Officer and President, Research & Development • Business Wire • 11/20/2024 11:45:00 AM
- European Commission Approves Pfizer’s HYMPAVZI™ (marstacimab) for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without Inhibitors • Business Wire • 11/20/2024 09:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2024 09:30:12 PM
Basanite, Inc. to Open New Production and Distribution Facility in Northeast Ohio • BASA • Jan 2, 2025 8:28 AM
The Crypto Company Highlights Blockchain Training Alliance's Successes and Momentum for 2025 • CRCW • Dec 26, 2024 8:58 AM
Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • HZLIF • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM